Loopbaan van Ashley Ivor Simon Morris
Eerdere bekende functies van Ashley Ivor Simon Morris
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SCIGEN LIMITED | Directeur/Bestuurslid | 14-02-2017 | 08-09-2017 |
| Algemeen Directeur | 09-02-2017 | 08-09-2017 | |
| MERCK SHARP DOHME PHARMA TBK PT | Corporate Officer/Principal | 01-01-2004 | 01-01-2009 |
Opleiding van Ashley Ivor Simon Morris
| The University of Nottingham | Undergraduate Degree |
Statistieken
Internationaal
| Singapore | 2 |
| Verenigd Koninkrijk | 2 |
| Indonesië | 2 |
Operationeel
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| MERCK SHARP DOHME PHARMA TBK PT | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
SciGen Pte Ltd.
 SciGen Pte Ltd. Pharmaceuticals: MajorHealth Technology SciGen Pte Ltd. engages in the development, manufacturing, and marketing of biopharmaceutical products. It operates through following segments: Singapore, Australia, Korea, Thailand, Philippines, China, and Others. The Singapore segment comprises of corporate office functions, sales, and marketing. The Australia, Korea, Thailand, and Philippines segments deal with sales and marketing activities. The China segment is involved in regulatory activities. The Others segment covers operations on in Indonesia, Pakistan, Vietnam, Hong Kong, Myanmar, Malaysia, and profit sharing income on sale of insulin. The firm's products include SciLin, SciTropin A, SciLocyte, SciTrace 5 Injection, and Heri Injection. The company was founded by Saul Akerib Mashaal in 1988 and is headquartered in Singapore. | Health Technology |
